The Dividend Yield as of December 2024 (TTM) for Denali Therapeutics Inc. (DNLI) is 0%

According to Denali Therapeutics Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Denali Therapeutics Inc. (DNLI) Historical Dividend Yield (quarterly & annually)

How has DNLI Dividend Yield performed in the past?

The mean historical Dividend Yield of Denali Therapeutics Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), DNLI's Dividend Yield was at its highest in in the March 2016 quarter at 0%. The Dividend Yield was at its lowest in in the March 2016 quarter at 0%.

Denali Therapeutics Inc. (DNLI) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Denali Therapeutics Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Denali Therapeutics Inc. (DNLI) Average Dividend Yield

How has DNLI Dividend Yield performed in the past?

The current Dividend Yield of Denali Therapeutics Inc. (DNLI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Denali Therapeutics Inc. (DNLI) Dividend Yield vs. Peers

How is DNLI’s Dividend Yield compared to its peers?

Denali Therapeutics Inc.’s Dividend Yield is less than Homology Medicines, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Atreca, Inc. (0%), less than Black Diamond Therapeutics, Inc. (0%), less than 4D Molecular Therapeutics, Inc. (0%), less than Ascendis Pharma A/S (0%), less than Apellis Pharmaceuticals, Inc. (0%), less than BeiGene, Ltd. (0%), less than Akero Therapeutics, Inc. (0%), less than Blueprint Medicines Corporation (0%), less than Legend Biotech Corporation (0%), less than Vaxcyte, Inc. (0%), less than Travere Therapeutics, Inc. (0%), less than Cerevel Therapeutics Holdings, Inc. (0%), less than Avidity Biosciences, Inc. (0%), less than Revolution Medicines, Inc. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than SpringWorks Therapeutics, Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Design Therapeutics, Inc. (0%), less than Werewolf Therapeutics, Inc. (0%), less than Ikena Oncology, Inc. (0%),

Build a custom stock screener for Denali Therapeutics Inc. (DNLI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Denali Therapeutics Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Denali Therapeutics Inc. (DNLI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Denali Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.